Private GP Dr Roy Melamed works for The Chelmsford Private Day Hospital and thinks the new sepsis test will be a huge step forward.
Private GP Dr Roy Melamed, from The Chelmsford Private Day Hospital, believes that this new test will be a "huge step forward", stating: "Checking kidney function, inflammatory parameters and blood cultures as well IL-6 can take up to 72 hours which of course delays diagnosis and, more importantly, treatment.
"The problem in most cases though is not the delay of 72 hours but the failure of the health-professionals to consider the diagnosis in the first place. Treatment can be started on suspicion alone while waiting for test results but without the suspicion that the presenting patient might indeed have sepsis, neither tests are ordered nor treatment is initiated.
"This new test, in my opinion, would lower the threshold of clinicians to initiate tests and with that it would hopefully be able to increase awareness. I believe it would overall prove of great benefit."
With an estimate of around 52,000 people in the UK dying from sepsis each year, the new test provides a great opportunity for science to save hundreds of lives.
Dr Ron Daniels BEM, CEO of the UK Sepsis Trust, told the University of Strathclyde that earlier diagnosis and treatment will save at least 14,000 lives a year: "Any kind of test that enables us to identify sepsis earlier, before symptoms even present themselves, could help save even more lives and bring us closer to our goal of ending preventable deaths from sepsis.
"Systems like this are so important as, with every hour before the right antibiotics are administered, risk of death increases. No test is perfect in the identification of sepsis, so it’s crucial we continue to educate clinicians to think sepsis in order to prompt them to use such tests."
Funded by Tenovus Scotland and the Dowager Countess Eleanor Peel Trust, Chair of Tenovus Scotland Strathclyde Professor Alan Foulis said: "Tenovus Scotland aims to support pilot scientific studies with real clinical potential, so this is an excellent example of the kind of research we like to fund.”